HN2001000277A - PIRROLO [2,1 - a] DIHIDROISOQUINOLINAS - Google Patents
PIRROLO [2,1 - a] DIHIDROISOQUINOLINASInfo
- Publication number
- HN2001000277A HN2001000277A HN2001000277A HN2001000277A HN2001000277A HN 2001000277 A HN2001000277 A HN 2001000277A HN 2001000277 A HN2001000277 A HN 2001000277A HN 2001000277 A HN2001000277 A HN 2001000277A HN 2001000277 A HN2001000277 A HN 2001000277A
- Authority
- HN
- Honduras
- Prior art keywords
- pirrolo
- dihydroisoquinolins
- dihydroisoquinolines
- phosphodiesterase
- inhibitors
- Prior art date
Links
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title abstract 2
- 101001072037 Homo sapiens cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102100036377 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Human genes 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
LA PRESENTE INVENCION SE REFIERE A PIRROLO [2, 1 - a] DIHIDROISOQUINOLINAS QUE SON INHIBIDORES DE LA FOSFODIESTERASA 10a, A UN PROCEDIMIENTO DE TRATAMIENTO DEL CANCER POR MEDIO DE LA ADMINISTRACION DE ESOS COMPUESTOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25520600P | 2000-12-13 | 2000-12-13 | |
US31031201P | 2001-08-06 | 2001-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2001000277A true HN2001000277A (es) | 2002-01-30 |
Family
ID=26944520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2001000277A HN2001000277A (es) | 2000-12-13 | 2001-12-12 | PIRROLO [2,1 - a] DIHIDROISOQUINOLINAS |
Country Status (10)
Country | Link |
---|---|
US (1) | US6930114B2 (es) |
EP (1) | EP1347973A1 (es) |
JP (1) | JP2004517843A (es) |
AU (1) | AU2002227985A1 (es) |
CA (1) | CA2431326A1 (es) |
HN (1) | HN2001000277A (es) |
PE (1) | PE20021085A1 (es) |
SV (1) | SV2002000761A (es) |
UY (1) | UY27067A1 (es) |
WO (1) | WO2002048144A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003014115A1 (en) * | 2001-08-06 | 2003-02-20 | Bayer Aktiengesellschaft | 3-substituted pyrrolo (2.1-a) isoquinoline derivatives |
WO2003014116A1 (en) * | 2001-08-06 | 2003-02-20 | Bayer Corporation | Pyrrolo[2.1-a]isoquinoline derivatives |
WO2003051877A1 (en) * | 2001-12-18 | 2003-06-26 | Bayer Corporation | 2-substituted pyrrolo[2.1-a]isoquinolines against cancer |
DE10230604A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Heterocyclisch substituierte Imidazotriazine |
US8338420B1 (en) | 2002-12-04 | 2012-12-25 | Mitsubishi Tanabe Pharma Corporation | Treatment of Parkinson's disease and enhancement of dopamine signal using PDE 10 inhibitor |
EP1578424A4 (en) * | 2002-12-12 | 2007-08-08 | Cytovia Inc | 1-BENZOYL-3-CYANO-PYRROLO 1,2-I A / I | SUBSTITUTED QUINOLINES AND THEIR ANALOGUES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS |
EP1641794A1 (en) * | 2003-06-30 | 2006-04-05 | ALTANA Pharma AG | Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
WO2005002579A1 (en) * | 2003-06-30 | 2005-01-13 | Altana Pharma Ag | Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
WO2006075012A2 (en) * | 2005-01-12 | 2006-07-20 | Nycomed Gmbh | Pyrrolodihydroisoquinolines as antiproliferative agents |
US20080161338A1 (en) * | 2005-01-12 | 2008-07-03 | Altana Pharma Ag | Novel Pyrrolodihydroisoquinolines as Pde 10 Inhibitors |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
EP2026813A2 (en) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
WO2008001182A1 (en) * | 2006-06-26 | 2008-01-03 | Pfizer Products Inc. | Tricyclic heteroaryl compounds as pde10 inhibitors |
US7998971B2 (en) | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
TW200944523A (en) * | 2008-02-08 | 2009-11-01 | Organon Nv | (Dihydro)pyrrolo[2,1-a]isoquinolines |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2507244B1 (en) | 2009-12-04 | 2014-11-05 | Nerviano Medical Sciences S.r.l. | Tricyclopyrazole derivatives |
EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
WO2015006689A1 (en) | 2013-07-12 | 2015-01-15 | University Of South Alabama | Treatment and diagnosis of cancer and precancerous conditions using pde10a inhibitors and methods to measure pde10a expression |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE690792A (es) | 1966-12-07 | 1967-05-16 | ||
FR7348M (es) * | 1967-12-07 | 1969-10-13 | ||
US4719216A (en) | 1983-06-23 | 1988-01-12 | Mcneilab, Inc. | Hexahydropyrrolo(2,1-A)isoquinoline derivatives as antidepressants |
DE3401018A1 (de) | 1984-01-13 | 1985-07-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Verfahren zur herstellung von 5,6-dihydro-pyrrolo(2,1-a)isochinolinen |
GB8718980D0 (en) | 1987-08-11 | 1987-09-16 | May & Baker Ltd | Compositions of matter |
IT1292092B1 (it) | 1997-06-05 | 1999-01-25 | Geange Ltd | Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali |
US6673564B2 (en) | 1999-10-18 | 2004-01-06 | Millennium Pharmaceuticals, Inc. | Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
-
2001
- 2001-12-04 EP EP01989571A patent/EP1347973A1/en not_active Withdrawn
- 2001-12-04 JP JP2002549675A patent/JP2004517843A/ja active Pending
- 2001-12-04 US US10/451,707 patent/US6930114B2/en not_active Expired - Fee Related
- 2001-12-04 CA CA002431326A patent/CA2431326A1/en not_active Abandoned
- 2001-12-04 WO PCT/EP2001/014187 patent/WO2002048144A1/en not_active Application Discontinuation
- 2001-12-04 AU AU2002227985A patent/AU2002227985A1/en not_active Abandoned
- 2001-12-12 UY UY27067A patent/UY27067A1/es not_active Application Discontinuation
- 2001-12-12 HN HN2001000277A patent/HN2001000277A/es unknown
- 2001-12-12 SV SV2001000761A patent/SV2002000761A/es unknown
-
2002
- 2002-04-23 PE PE2002000338A patent/PE20021085A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1347973A1 (en) | 2003-10-01 |
US20040138249A1 (en) | 2004-07-15 |
CA2431326A1 (en) | 2002-06-20 |
JP2004517843A (ja) | 2004-06-17 |
WO2002048144A1 (en) | 2002-06-20 |
PE20021085A1 (es) | 2003-05-16 |
SV2002000761A (es) | 2002-12-02 |
US6930114B2 (en) | 2005-08-16 |
AU2002227985A1 (en) | 2002-06-24 |
UY27067A1 (es) | 2002-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2001000277A (es) | PIRROLO [2,1 - a] DIHIDROISOQUINOLINAS | |
HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
AU3652102A (en) | Compounds and their uses | |
ECSP034568A (es) | Inhibidores de metaloproteinasa del tipo pirimidin 2,4,6-triona | |
CR7182A (es) | Benzoilsufanamidas y sulfonilbenzamidinas que se usan como agentes antitumorales | |
MXPA02007915A (es) | Mediador de lipido activado por aspirina. | |
HN2000000137A (es) | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas | |
EA200101046A1 (ru) | Производные индигоидных бис-индолов | |
CY1106366T1 (el) | Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου | |
ATE355278T1 (de) | Isochinolinon derivate als parp inhibitoren | |
HN2002000208A (es) | 1-ALQUIL O 1 - CICLOALQUIL-TRIAZOLO [4.3 - a] QUINAZOLIN -5-ONAS COMO INHIBIDORES DE FOSFODIESTERASAS | |
NO20026255D0 (no) | Polymere micelle sammensetninger | |
DK1224172T3 (da) | Medikamenter til behandling af ondartede tumorer | |
HK1052940A1 (en) | Synthetic methods for aplidine and new antitumoralderivatives, methods of making and using them | |
ATE405568T1 (de) | Cytotoxische mittel | |
NI200300045A (es) | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
HN1998000091A (es) | Inhibidores de la farnesil transferasa tratamiento del cancer. | |
EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
HUP0202592A2 (hu) | Lazofoxifen transzdermális adagolása | |
TR200302134T4 (tr) | 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı. | |
MXPA04003910A (es) | Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar. | |
HRP20040186B1 (en) | Use of lhrh-antagonists for the improvement of t-cell mediated immunity | |
ATE374203T1 (de) | Therapeutische verbindungen und verfahren |